(0)サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1547126

無血清培地市場：世界の産業分析、規模、シェア、成長、動向、2024-2033年予測

Serum Free Media Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
無血清培地市場：世界の産業分析、規模、シェア、成長、動向、2024-2033年予測
出版日: 2024年08月28日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界の無血清培地市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題など、重要な市場力学を詳細に分析し、市場構造に関する詳細な洞察を提供しています。

主な洞察

  • 無血清培地の市場規模（2024E）：20億米ドル
  • 予測市場規模（2033F）：38億米ドル
  • 世界市場成長率（CAGR 2024年から2033年まで）：7.7%

無血清培地市場- レポート範囲：

無血清培地は、動物由来成分による汚染のリスクを排除するため、特に治療・診断目的の細胞培養アプリケーションに不可欠です。同市場は、バイオテクノロジー、製薬、学術研究など幅広い業界にサービスを提供し、特定の細胞株や用途に合わせた様々なタイプの無血清培地を提供しています。市場の成長は、生物製剤に対する需要の増加、細胞培養技術の進歩、ワクチン生産やその他の治療開発における無血清培地の採用の増加によって促進されています。

市場成長の促進要因：

世界の無血清培地市場は、安全性と規制遵守を向上させるために、細胞培養における動物由来成分の使用を減らすことが重視されるようになるなど、いくつかの重要な要因によって牽引されています。モノクローナル抗体やワクチンなどのバイオ医薬品に対する需要の増加は、より一貫性のある明確な培養環境を保証するため、無血清培地の採用を後押ししています。さらに、細胞培養技術の進歩や特定の細胞株に合わせた無血清製剤の市場開拓が、市場の成長に寄与しています。個別化医療の推進や再生医療における細胞ベースの研究の拡大も、無血清培地の需要促進に重要な役割を果たしています。

市場抑制要因：

有望な成長見通しにもかかわらず、無血清培地市場は高い市場開拓コストと技術的複雑性に関連する課題に直面しています。無血清培地の製剤化には、さまざまな細胞株との適合性を確保するための広範な研究開発努力が必要であり、これが生産コストを上昇させる可能性があります。さらに、血清含有培地から無血清培地への移行は、広範なバリデーションと最適化プロセスが必要なため、研究者にとって困難なものとなりうる。従来の培地と比較して無血清培地のコストが高いことも、特に小規模の研究所や研究機関にとっては制限要因となりうる。

市場機会：

無血清培地市場は、バイオ医薬品研究開発への投資の増加、生物製剤やバイオシミラーの台頭、細胞治療や遺伝子治療への注目の高まりによって、大きな成長機会をもたらしています。幹細胞培養や3D細胞培養など、特定の用途に対応する新規無血清培地製剤の開拓は、市場拡大の新たな道を提供します。さらに、持続可能で倫理的な研究慣行が重視されるようになり、無血清培地の採用がさらに促進されると予想されます。研究機関やバイオ製薬企業との戦略的パートナーシップは、技術革新やコスト効率の高いソリューションへの投資とともに、こうした新たな機会を活用する上で極めて重要です。

本レポートで扱う主な質問

  • 無血清培地市場の世界的成長を促進する主な要因は何か？
  • 無血清培地の種類と製剤はどのような業界で採用されているか？
  • 技術の進歩は無血清培地市場の競合情勢にどのような影響を与えているか？
  • 無血清培地市場に貢献している主要プレイヤーは誰で、市場の関連性を維持するためにどのような戦略を採用しているのか？
  • 世界の無血清培地市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 市場の革新/開発動向

第4章 重要成功要因

  • 主な規制
  • メーカーによる主要戦略の採用
  • 製品採用分析
  • 主要開発分析
  • サプライチェーン分析
  • パイプライン評価
  • PESTEL分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • メディア別
    • エンドユーザー別
    • 国別
  • 2024年の市場シナリオ

第7章 世界市場の需要（価値または規模、10億米ドル）分析

  • 市場金額（10億米ドル）分析、2019～2023年
  • 市場分類別の市場規模（10億米ドル）の分析と予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第8章 培地別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（10億米ドル）分析、2019～2023年
  • 市場規模（10億米ドル）分析と予測、2024～2033年
    • タンパク質発現培地
    • 幹細胞培地
    • ハイブリドーマ培地
    • 一次細胞培地
    • 昆虫細胞培地
    • 免疫学培地
    • CHO細胞培地
    • 化学的定義培地
  • 培地別市場の魅力分析

第9章 エンドユーザー別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（10億米ドル）分析、2019～2023年
  • 市場規模（10億米ドル）分析と予測、2024～2033年
    • バイオ医薬品企業
    • 臨床研究機関
    • 学術研究センター
  • エンドユーザー別市場の魅力分析

第10章 地域別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（10億米ドル）分析、2019～2023年
  • 市場規模（10億米ドル）分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 地域別市場の魅力分析

第11章 北米市場分析

第12章 ラテンアメリカ市場分析

第13章 欧州市場分析

第14章 東アジア市場分析

第15章 南アジア市場分析

第16章 オセアニア市場

第17章 中東・アフリカ市場分析

第18章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第19章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE Healthcare
    • Lonza
    • Corning Incorporated
    • Irvine Scientific
    • STEMCELL Technologies
    • PAN Biotech
    • MP Biomedicals, LLC
    • PromoCell GmbH
    • Sartorius AG

第20章 使用される前提条件と頭字語

第21章 調査手法

目次
Product Code: PMRREP15373

Persistence Market Research has recently released a comprehensive report on the global Serum Free Media Market. The report provides an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

  • Serum Free Media Market Size (2024E): USD 2.0 Bn
  • Projected Market Value (2033F): USD 3.8 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 7.7%

Serum Free Media Market - Report Scope:

Serum free media are essential in cell culture applications, particularly for therapeutic and diagnostic purposes, as they eliminate the risk of contamination associated with animal-derived components. The market serves a wide range of industries, including biotechnology, pharmaceuticals, and academic research, providing various types of serum free media tailored for specific cell lines and applications. The market's growth is fueled by the increasing demand for biologics, advancements in cell culture technologies, and the rising adoption of serum free media in vaccine production and other therapeutic developments.

Market Growth Drivers:

The global serum free media market is driven by several key factors, including the growing emphasis on reducing the use of animal-derived components in cell culture to improve safety and regulatory compliance. The increasing demand for biopharmaceuticals, such as monoclonal antibodies and vaccines, is boosting the adoption of serum free media, as it ensures a more consistent and defined culture environment. Additionally, advancements in cell culture technologies and the development of tailored serum free formulations for specific cell lines are contributing to market growth. The push towards personalized medicine and the expansion of cell-based research in regenerative medicine also play significant roles in driving demand for serum free media.

Market Restraints:

Despite promising growth prospects, the serum free media market faces challenges related to high development costs and technical complexities. The formulation of serum free media requires extensive R&D efforts to ensure compatibility with different cell lines, which can increase production costs. Additionally, the transition from serum-containing to serum free media can be challenging for researchers due to the need for extensive validation and optimization processes. The high cost of serum free media compared to traditional media can also be a limiting factor, particularly for small-scale laboratories and research institutions.

Market Opportunities:

The serum free media market presents significant growth opportunities driven by increasing investments in biopharmaceutical R&D, the rise of biologics and biosimilars, and the growing focus on cell and gene therapy. The development of novel serum free media formulations that cater to specific applications, such as stem cell culture and 3D cell culture, offers new avenues for market expansion. Additionally, the growing emphasis on sustainable and ethical research practices is expected to further drive the adoption of serum free media. Strategic partnerships with research institutions and biopharmaceutical companies, along with investment in innovation and cost-effective solutions, are crucial to capitalizing on these emerging opportunities.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the serum free media market globally?
  • Which serum free media types and formulations are leading adoption across different industries?
  • How are technological advancements influencing the competitive landscape of the serum free media market?
  • Who are the key players contributing to the serum free media market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global serum free media market?

Competitive Intelligence and Business Strategy:

Leading players in the global serum free media market, including Thermo Fisher Scientific, Merck KGaA, and Lonza Group, focus on innovation, product differentiation, and strategic collaborations to maintain a competitive edge. These companies invest in R&D to develop advanced serum free media solutions tailored for various cell lines and applications, ensuring compliance with stringent regulatory standards. Partnerships with biopharmaceutical companies, academic institutions, and research organizations facilitate market access and promote the adoption of serum free media. The emphasis on sustainability, ethical research practices, and performance enhancement drives market growth and reinforces the position of key players in the evolving life sciences sector.

Key Companies Profiled:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GE Healthcare
  • Lonza
  • Corning Incorporated
  • Irvine Scientific
  • STEMCELL Technologies
  • PAN Biotech
  • MP Biomedicals, LLC
  • PromoCell GmbH
  • Sartorius AG

Key Segments Covered in Serum free media Industry Research

Media:

  • Protein Expression Media
  • Stem Cell Media
  • Hybridoma Media
  • Primary Cell Media
  • Insect Cell Media
  • Immunology Media
  • Chinese Hamster Ovary (CHO) Cell Culture Media

End User:

  • Biopharmaceutical Companies
  • Clinical Research Organizations
  • Academic Research Centers

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Regulations
  • 4.2. Key Strategies Adoption by Manufacturers
  • 4.3. Product Adoption Analysis
  • 4.4. Key Development Analysis
  • 4.5. Supply Chain Analysis
  • 4.6. Pipeline Assessment
  • 4.7. PESTEL Analysis
  • 4.8. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Cell Culture Media Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Growing Healthcare Expenditure
    • 5.2.2. Demand for Serum-Free Media
    • 5.2.3. Increase in Research and Development Funding and Grants
    • 5.2.4. Increase in Academic Research
    • 5.2.5. Industry Consolidation Activities
    • 5.2.6. Historic and Current Revenue of key Players
    • 5.2.7. Increasing Number of Clinical Research Activities
    • 5.2.8. Increasing Number of Biopharmaceutical Research Activities
    • 5.2.9. Cost of Manufacturing Serum Free Media
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Media
    • 6.1.2. By End User
    • 6.1.3. By Country
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Media

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis by Media, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Media, 2024-2033
    • 8.3.1. Protein Expression Media
    • 8.3.2. Stem Cell Media
    • 8.3.3. Hybridoma Media
    • 8.3.4. Primary Cell Media
    • 8.3.5. Insect Cell Media
    • 8.3.6. Immunology Media
    • 8.3.7. CHO Cell Media
    • 8.3.8. Chemically Defined Media
  • 8.4. Market Attractiveness Analysis by Media

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2033
    • 9.3.1. Biopharmaceutical Companies
    • 9.3.2. Clinical Research Organizations
    • 9.3.3. Academic Research Centers
  • 9.4. Market Attractiveness Analysis by End User

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis Forecast by Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East & Africa
  • 10.4. Market Attractiveness Analysis by Region

11. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Media
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Media
    • 11.4.3. By End User
  • 11.5. Market Trends
  • 11.6. Key Market Participants - Intensity Mapping
  • 11.7. Drivers and Restraints - Impact Analysis
  • 11.8. Country Level Analysis & Forecast
    • 11.8.1. U.S. Market
      • 11.8.1.1. Introduction
      • 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.1.2.1. By Media
        • 11.8.1.2.2. By End User
    • 11.8.2. Canada Market
      • 11.8.2.1. Introduction
      • 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.2.2.1. By Media
        • 11.8.2.2.2. By End User

12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. Mexico
      • 12.3.1.2. Brazil
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Media
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Media
    • 12.4.3. By End User
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. Mexico Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Media
        • 12.8.1.2.2. By End User
    • 12.8.2. Brazil Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Media
        • 12.8.2.2.2. By End User
    • 12.8.3. Argentina Market Analysis
      • 12.8.3.1. Introduction
      • 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.3.2.1. By Media
        • 12.8.3.2.2. By End User

13. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. Italy
      • 13.3.1.3. France
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. BENELUX
      • 13.3.1.7. Russia
      • 13.3.1.8. Rest of Europe
    • 13.3.2. By Media
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Media
    • 13.4.3. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Germany Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Media
        • 13.8.1.2.2. By End User
    • 13.8.2. Italy Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Media
        • 13.8.2.2.2. By End User
    • 13.8.3. France Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Media
        • 13.8.3.2.2. By End User
    • 13.8.4. U.K. Market Analysis
      • 13.8.4.1. Introduction
      • 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.4.2.1. By Media
        • 13.8.4.2.2. By End User
    • 13.8.5. Spain Market Analysis
      • 13.8.5.1. Introduction
      • 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.5.2.1. By Media
        • 13.8.5.2.2. By End User
    • 13.8.6. BENELUX Market Analysis
      • 13.8.6.1. Introduction
      • 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.6.2.1. By Media
        • 13.8.6.2.2. By End User
    • 13.8.7. Russia Market Analysis
      • 13.8.7.1. Introduction
      • 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.7.2.1. By Media
        • 13.8.7.2.2. By End User

14. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Media
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Media
    • 14.4.3. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. China Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Media
        • 14.8.1.2.2. By End User
    • 14.8.2. Japan Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Media
        • 14.8.2.2.2. By End User
    • 14.8.3. South Korea Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Media
        • 14.8.3.2.2. By End User

15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Malaysia
      • 15.3.1.4. Thailand
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Media
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Media
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Media
        • 15.8.1.2.2. By End User
    • 15.8.2. Indonesia Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Media
        • 15.8.2.2.2. By End User
    • 15.8.3. Malaysia Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Media
        • 15.8.3.2.2. By End User
    • 15.8.4. Thailand Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Media
        • 15.8.4.2.2. By End User

16. Oceania Market 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Media
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Media
    • 16.4.2. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Australia Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Media
        • 16.8.1.2.2. By End User
    • 16.8.2. New Zealand Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Media
        • 16.8.2.2.2. By End User

17. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkiye
      • 17.3.1.3. North Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Media
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Media
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. GCC Countries Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Media
        • 17.8.1.2.2. By End User
    • 17.8.2. Turkiye Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Media
        • 17.8.2.2.2. By End User
    • 17.8.3. South Africa Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Media
        • 17.8.3.2.2. By End User
    • 17.8.4. North Africa Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Media
        • 17.8.4.2.2. By End User

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Thermo Fisher Scientific Inc.
      • 19.3.1.1. Overview
      • 19.3.1.2. Media Portfolio
      • 19.3.1.3. Sales Footprint
      • 19.3.1.4. Key Financials
      • 19.3.1.5. SWOT Analysis
      • 19.3.1.6. Key Developments
      • 19.3.1.7. Strategy Overview
        • 19.3.1.7.1. Marketing Strategy
        • 19.3.1.7.2. Media Strategy
        • 19.3.1.7.3. Channel Strategy
    • 19.3.2. Merck KGaA
      • 19.3.2.1. Overview
      • 19.3.2.2. Media Portfolio
      • 19.3.2.3. Sales Footprint
      • 19.3.2.4. Key Financials
      • 19.3.2.5. SWOT Analysis
      • 19.3.2.6. Key Developments
      • 19.3.2.7. Strategy Overview
        • 19.3.2.7.1. Marketing Strategy
        • 19.3.2.7.2. Media Strategy
        • 19.3.2.7.3. Channel Strategy
    • 19.3.3. GE Healthcare
      • 19.3.3.1. Overview
      • 19.3.3.2. Media Portfolio
      • 19.3.3.3. Sales Footprint
      • 19.3.3.4. Key Financials
      • 19.3.3.5. SWOT Analysis
      • 19.3.3.6. Key Developments
      • 19.3.3.7. Strategy Overview
        • 19.3.3.7.1. Marketing Strategy
        • 19.3.3.7.2. Media Strategy
        • 19.3.3.7.3. Channel Strategy
    • 19.3.4. Lonza
      • 19.3.4.1. Overview
      • 19.3.4.2. Media Portfolio
      • 19.3.4.3. Sales Footprint
      • 19.3.4.4. Key Financials
      • 19.3.4.5. SWOT Analysis
      • 19.3.4.6. Key Developments
      • 19.3.4.7. Strategy Overview
        • 19.3.4.7.1. Marketing Strategy
        • 19.3.4.7.2. Media Strategy
        • 19.3.4.7.3. Channel Strategy
    • 19.3.5. Corning Incorporated
      • 19.3.5.1. Overview
      • 19.3.5.2. Media Portfolio
      • 19.3.5.3. Sales Footprint
      • 19.3.5.4. Key Financials
      • 19.3.5.5. SWOT Analysis
      • 19.3.5.6. Key Developments
      • 19.3.5.7. Strategy Overview
        • 19.3.5.7.1. Marketing Strategy
        • 19.3.5.7.2. Media Strategy
        • 19.3.5.7.3. Channel Strategy
    • 19.3.6. Irvine Scientific
      • 19.3.6.1. Overview
      • 19.3.6.2. Media Portfolio
      • 19.3.6.3. Sales Footprint
      • 19.3.6.4. Key Financials
      • 19.3.6.5. SWOT Analysis
      • 19.3.6.6. Key Developments
      • 19.3.6.7. Strategy Overview
        • 19.3.6.7.1. Marketing Strategy
        • 19.3.6.7.2. Media Strategy
        • 19.3.6.7.3. Channel Strategy
    • 19.3.7. STEMCELL Technologies
      • 19.3.7.1. Overview
      • 19.3.7.2. Media Portfolio
      • 19.3.7.3. Sales Footprint
      • 19.3.7.4. Key Financials
      • 19.3.7.5. SWOT Analysis
      • 19.3.7.6. Key Developments
      • 19.3.7.7. Strategy Overview
        • 19.3.7.7.1. Marketing Strategy
        • 19.3.7.7.2. Media Strategy
        • 19.3.7.7.3. Channel Strategy
    • 19.3.8. PAN Biotech
      • 19.3.8.1. Overview
      • 19.3.8.2. Media Portfolio
      • 19.3.8.3. Sales Footprint
      • 19.3.8.4. Key Financials
      • 19.3.8.5. SWOT Analysis
      • 19.3.8.6. Key Developments
      • 19.3.8.7. Strategy Overview
        • 19.3.8.7.1. Marketing Strategy
        • 19.3.8.7.2. Media Strategy
        • 19.3.8.7.3. Channel Strategy
    • 19.3.9. MP Biomedicals, LLC
      • 19.3.9.1. Overview
      • 19.3.9.2. Media Portfolio
      • 19.3.9.3. Sales Footprint
      • 19.3.9.4. Key Financials
      • 19.3.9.5. SWOT Analysis
      • 19.3.9.6. Key Developments
      • 19.3.9.7. Strategy Overview
        • 19.3.9.7.1. Marketing Strategy
        • 19.3.9.7.2. Media Strategy
        • 19.3.9.7.3. Channel Strategy
    • 19.3.10. PromoCell GmbH
      • 19.3.10.1. Overview
      • 19.3.10.2. Media Portfolio
      • 19.3.10.3. Sales Footprint
      • 19.3.10.4. Key Financials
      • 19.3.10.5. SWOT Analysis
      • 19.3.10.6. Key Developments
      • 19.3.10.7. Strategy Overview
        • 19.3.10.7.1. Marketing Strategy
        • 19.3.10.7.2. Media Strategy
        • 19.3.10.7.3. Channel Strategy
    • 19.3.11. Sartorius AG
      • 19.3.11.1. Overview
      • 19.3.11.2. Media Portfolio
      • 19.3.11.3. Sales Footprint
      • 19.3.11.4. Key Financials
      • 19.3.11.5. SWOT Analysis
      • 19.3.11.6. Key Developments
      • 19.3.11.7. Strategy Overview
        • 19.3.11.7.1. Marketing Strategy
        • 19.3.11.7.2. Media Strategy
        • 19.3.11.7.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology